Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02812693 |
Title | Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Joanne Jeter |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries |
Facility | Status | City | State | Zip | Country | Details |
---|